See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.90▲ 2.00%
← 0S9E page
XStocksXray
Market X-Ray report · 27 October 2026

Extendicare Inc. (0S9E)

London Stock Exchange · UK · prices in CAD · close of 27 Oct 2026

Key indicators

Last closeCAD 26.88
52-week range19.85 – 39.00
Return, 1 month / 3 months−13.0% / −29.2%
Return, 1 year / 3 years– / –
TrendBelow its 200-day average
RSI (14)38
Volatility (1 year)38.8%
Worst drawdown (1 year)-30.9%
Average daily value traded0.00M CAD
Dividend yield–

Market X-Ray price-based

28/ 100 · Medium confidence · ahead of 17% of stocks on this exchange
Trend32
Momentum19
Stability (higher is calmer)45
Liquidity8
Income–

Five-year price chart navy: price · brown: 200-day average

3.5212.7722.0231.2740.522021-102025-122026-042026-072026-10

About the company

Extendicare Inc. provides senior care services, operating long-term care homes and retirement communities where residents receive nursing and personal care. The company also offers home health care, helping people who need support while living in their own homes. Its customers are mainly older adults and their families, along with health authorities that fund care places. Extendicare is based in Canada and focuses its operations on Canadian communities.

On this site Extendicare Inc. appears as a stock on the London Stock Exchange (UK), code 0S9E, with prices in Canadian dollars (CAD). Dividend data for this stock is not available yet. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Extendicare Inc. (0S9E) trades on the London Stock Exchange in UK. It last closed at CAD 26.88 on 27 October 2026.

Its price-based Market X-Ray is 28 out of 100 (a weak price profile), ranking 3,152 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Extendicare Inc. (0S9E)

The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange

Lens and metricValueScoreReading
Trend32 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-10.4%
From 52-week high-30.3%
Momentum19 · WeakLagging most stocks on this exchange.
3-month return-29.2%
6-month return-9.2%
12-month return, skipping the last month–
Stability (higher is calmer)45 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)38.8%
Worst drawdown, 1 year (smaller is calmer)-30.9%
Liquidity8 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M CAD
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.1%
1 month−13.0%
3 months−29.2%
6 months−9.2%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average29.70 / 29.99
Golden / death cross (60 days)Death, 2 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.68

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 7 bearish
MonthlyBullish4 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026